back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-08-01 15:57 Tx date 2024-08-01 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Levine, Mitchell
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,156
+10,000 vol $0.82 each |
30,000 | |
| Filed 2024-04-05 10:06 Tx date 2024-03-21 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Levine, Mitchell
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,256
+10,000 vol $1.43 each |
20,000 | |
| Filed 2024-01-25 11:23 Tx date 2024-01-19 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Levine, Mitchell
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$29,600
+20,000 vol $1.48 each |
60,000 | |
| Filed 2024-01-25 11:08 Tx date 2024-01-19 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Levine, Mitchell
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$59,200
+40,000 vol $1.48 each |
40,000 | |
| Filed 2024-01-25 11:07 Tx date 2023-11-09 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Levine, Mitchell
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-12-20 10:17 Tx date 2023-12-18 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Levine, Mitchell
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,834
+10,000 vol $1.38 each |
10,000 | |
| Filed 2023-12-20 10:15 Tx date 2023-11-09 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Levine, Mitchell
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|